Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
While there has been much recent interest in the relationship between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs), little has been reported about ADHD diagnostic subtypes, persistence of symptoms from childhood into adulthood, and substance of choice in individuals with substance use disorders (SUD+) and comorbid ADHD. To examine the prevalence and subtypes of ADHD in a group of SUD+ individuals, 136 inpatients with an SUD diagnosis (cocaine vs. alcohol vs. cocaine/alcohol) were administered a structured interview for ADHD. Of the SUD+ individuals, 32% met criteria for ADHD, and 35% of those with a childhood diagnosis of ADHD continued to have clinically significant symptoms into adulthood. There were no significant differences in the percentage of ADHD between the SUD+ groups divided by drug choice. Of ADHD subtypes, subjects with combined and inattentive types were significantly more likely to have symptoms continue into adulthood (p < or = .05) than the hyperactive/impulsive subtype. Patients with cocaine use were more likely to have ADHD in childhood only when compared to the alcohol or cocaine-alcohol groups. The findings of this study indicate that ADHD is prevalent in treatment-seeking substance users without difference in prevalence or subtype by drug choice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700
Cited by
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.01.006 · Cited by 875
“…there is a sizable body of research suggesting that ADHD is associated with elevated substance use and related disorders (e.g., Boyle et al., 1993; Clure et al., 1999; Disney, Elkins, McGue, & Iacono, 1999; Katusic et al., 2005; Mannuzza, Klein, Bessler, Malloy, & LaPadula, 1998; Milberger,…”
BackgroundFranklin, T. R., Acton, P. D., Maldjian, J. A., Gray, J. D., Croft, J. R., Dackis, C. A., O’Brien, C. P., & Childress, A. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01269-0 · Cited by 600
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 393
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD)
Sobanski, E. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-1004-4 · Cited by 340
Brandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259
Gerard Moeller, F., Dougherty, D. M., Barratt, E. S., Oderinde, V., Mathias, C. W., Andrew Harper, R., & Swann, A. C. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00106-0 · Cited by 257
Monoamine transporters and psychostimulant addiction
Howell, L. L., & Kimmel, H. L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.003 · Cited by 255
Schubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220
Arias, A. J., Gelernter, J., Chan, G., Weiss, R. D., Brady, K. T., Farrer, L., & Kranzler, H. R. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.05.003 · Cited by 211
Self-citationvan de Glind, G., van den Brink, W., Koeter, M. W. J., Carpentier, P.-J., van Emmerik-van Oortmerssen, K., Kaye, S., Skutle, A., Bu, E.-T. H., Franck, J., Konstenius, M., et al. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.010 · Cited by 189
“…of treatent seeking adult SUD patients, the prevalence of adult ADHD is ubstantially higher, ranging from 10% to 46% (Van Emmerik-van ortmerssen et al., 2012; Levin et al., 1998; Clure et al., 1999; King t al., 1999; Schubiner et al., 2007; Wilens, 2004; Yewers et al., 005; Matsumoto et al., 2005).”
BackgroundThe placebo effect in neurological disorders
de la Fuente-Fernández, R., Schulzer, M., & Stoessl, A. J. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00038-8 · Cited by 187
SULLIVAN, M. A., & RUDNIK‐LEVIN, F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05783.x · Cited by 172
Treatment Strategies for Co-Occurring ADHD and Substance Use Disorders
Mariani, J. J., & Levin, F. R. (2007) · The American Journal on Addictions · doi:10.1080/10550490601082783 · Cited by 153
Ernst, M., Luckenbaugh, D. A., Moolchan, E. T., Leff, M. K., Allen, R., Eshel, N., London, E. D., & Kimes, A. (2006) · Pediatrics · doi:10.1542/peds.2005-0704 · Cited by 137
Adult ADHD and Substance Abuse: Diagnostic and Treatment Issues
Kalbag, A. S., & Levin, F. R. (2005) · Substance Use & Misuse · doi:10.1080/10826080500294858 · Cited by 104
Rohner, H., Gaspar, N., Philipsen, A., & Schulze, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021275 · Cited by 90
Daigre, C., Roncero, C., Grau‐López, L., Martínez‐Luna, N., Prat, G., Valero, S., Tejedor, R., Ramos‐Quiroga, J. A., & Casas, M. (2013) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12047.x · Cited by 52
Panagiotidi, M., & Overton, P. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2018.08.004 · Cited by 45
KIM, J.-W., PARK, C.-S., HWANG, J.-W., SHIN, M.-S., HONG, K.-E., CHO, S.-C., & KIM, B.-N. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl034 · Cited by 43
Symptom Prevalence of ADHD in a Community Residential Substance Abuse Treatment Program
McAweeney, M., Rogers, N. L., Huddleston, C., Moore, D., & Gentile, J. P. (2010) · Journal of Attention Disorders · doi:10.1177/1087054708329973 · Cited by 37
“Clure et al. (1999) found a 32% rate of ADHD among treatment-seeking clients.”
BackgroundInfluentialGoossensen, M. A., van de Glind, G., Carpentier, P.-J., Wijsen, R. M. A., van Duin, D., & Kooij, J. J. S. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.12.004 · Cited by 26
“In comparison, American research shows the percentage of ADHD among substance abusers on treatments, which varies between 6.7% and 25% ( Clure, Brady, Saladin, Johnson, & Rittenbury, 1999; King, 1999; Schubiner et al., 2000).”
BackgroundInfluential
Metadata
- Authors
- Clure, C., Brady, K. T., Saladin, M. E., Johnson, D., Waid, R., & Rittenbury, M.
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 1999-01-01
- Volume
- 25
- Issue
- 3
- Pages
- 441-448
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2075749580
- Cited by
- 135
- References
- 3
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.